Carmen De Mendoza Fernandez-rekin lankidetzan egindako argitalpenak (278)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Drug Design, Development and Therapy, Vol. 17, pp. 155-166

  3. COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study

    International Journal of Infectious Diseases, Vol. 134, pp. 154-159

  4. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  5. HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection

    AIDS Reviews

  6. HTLV infection in persons with sexually transmitted diseases in Spain

    Frontiers in Immunology, Vol. 14

  7. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

  8. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  9. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  10. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

    Autoimmunity Reviews, Vol. 22, Núm. 6

  11. Predictors of in-hospital mortality in HIV-infected patients with COVID-19

    QJM, Vol. 116, Núm. 1, pp. 57-62

  12. Rebound in sexually transmitted infections after the COVID-19 pandemic

    AIDS reviews, Vol. 26, Núm. 3, pp. 127-135

  13. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  14. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020